Cyromazine is an insect growth regulator (IGR) or ectoparasiticide that disrupts the development of insects and is effective against leaf miners and fly larvae. Increasing population and rising disposable income of the population is resulting in huge demand for food items and agriculture products, which in turn increases the demand for IGRs.
Market Dynamics
Among application, crop protection segment is gaining traction in market, owing to increasing need for pest control in agriculture. For instance, according to Coherent Market Insights’ analysis, the global pest control services market was valued around US$ 16.18 Million in 2021. Cyromazine insect growth regulator possesses various advantages such as low toxicity and lesser impact on human health, and long-term effect, which are expected to moderately impact growth of the global cyromazine market.
Asia Pacific held a significant market share in 2021 due to substantial demand for cyromazine from China, India, South Korea, and Japan. Rising demand for agrochemicals, owing to increasing population in turn increases demand for agricultural products, thereby aiding in growth of the cyromazine market.
Key features of the study:
- This report provides an in-depth analysis of global cyromazine market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2030), considering 2021 as the base year
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global cyromazine market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
- Key companies covered as a part of this study include Syngenta AG, ADAMA Agricultural Solutions Ltd., Elanco Animal Health Inc., Jurox Pty Limited., Arysta LifeScience Corporation, Lasa Supergenerics Limited, Orion AgriScience Limited, Topsen Biotech Co. Ltd., Shandong Luxi Animal Medicine Share Co., Ltd., Bayer AG, and Toronto Research Chemicals Inc.
- Insights from this report would allow marketers and management authorities of companies to make informed decision regarding future product launches, technology up gradation, market expansion, and marketing tactics
- The global cyromazine market report caters to various stakeholders in this industry including investors, suppliers, Cyromazine manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Cyromazine market
Detailed Segmentation:
- Global Cyromazine Market, By Application :
- Crop Protection
- Veterinary Medicines
- Global Cyromazine Market, By Region:
- North America
- Latin America
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Country:
- Germany
- U.K
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Country:
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- Company Profiles
- Syngenta AG
- Company Overview
- Product Portfolio
- Key Strategies
- Recent Developments
- Future Plans
- ADAMA Agricultural Solutions Ltd.
- Elanco Animal Health Inc.
- Jurox Pty Limited.
- Arysta LifeScience Corporation
- Lasa Supergenerics Limited
- Orion AgriScience Limited
- Topsen Biotech Co. Ltd.
- Shandong Luxi Animal Medicine Share Co., Ltd.
- Bayer AG
- Toronto Research Chemicals Inc.
“*” marked represents similar segmentation in other categories in the respective section
